Trematode infection acquired through freshwater contact in endemic regions; causes hepatic, intestinal, and urogenital disease.
Also known as: schistosomiasis, bilharzia, Schistosoma mansoni, Schistosoma haematobium, Schistosoma japonicum, swimmer's itch
Overview
Chronic parasitic infection caused by blood-dwelling trematodes (flukes) of the genus Schistosoma. Three species cause most human disease: S. mansoni (intestinal/hepatic, Africa, Middle East, South America, Caribbean), S. haematobium (urogenital, Africa, Middle East), and S. japonicum (intestinal/hepatic, Asia). S. mekongi and S. intercalatum are regional species.
Epidemiology
Affects more than 200 million people globally; among the most prevalent parasitic diseases worldwide. Transmission requires freshwater contact in endemic regions where intermediate snail hosts are present. Sub-Saharan Africa carries the largest burden. Travelers, refugees, and immigrants are common patients in non-endemic countries.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Schistosomiasis outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Freshwater contact (swimming, bathing, wading, fishing, occupational exposure) in endemic regions
Residence in or travel to sub-Saharan Africa, Egypt, Brazil, parts of Asia and the Middle East
Lack of safe water and sanitation
Refugee or migrant populations from endemic regions
Age 10-20 years (peak prevalence)
Pathophysiology
Cercariae released from infected freshwater snails penetrate intact human skin → migrate to lungs and liver → mature into adult worm pairs in mesenteric venules (S. mansoni, japonicum) or vesical venules (S. haematobium). Adult females release eggs that traverse tissue into the bowel or bladder; eggs trapped in tissues drive granulomatous inflammation and fibrosis. Chronic disease reflects egg-induced tissue damage rather than the worms themselves.
Clinical presentation
Symptoms
Cercarial dermatitis (swimmer's itch) — pruritic papular rash at penetration site within hours to days
Katayama fever (acute schistosomiasis) 4-8 weeks after exposure: fever, urticaria, eosinophilia, hepatosplenomegaly, cough — coincides with egg laying
Intestinal: chronic abdominal pain, intermittent diarrhea, blood in stool
Hepatosplenic: hepatosplenomegaly with periportal fibrosis ('pipestem' or Symmers fibrosis), variceal bleeding, ascites
Urogenital (S. haematobium): terminal hematuria, dysuria, hematospermia, infertility, bladder polyps and ulcers; long-term: squamous cell carcinoma of the bladder
Returned traveler or immigrant from sub-Saharan Africa with hematuria (S. haematobium) or hepatosplenomegaly and esophageal varices despite normal synthetic function (S. mansoni). Eosinophilia and characteristic eggs on urine or stool microscopy with the species-specific spine: lateral spine = S. mansoni, terminal spine = S. haematobium, no spine or tiny lateral knob = S. japonicum.
Differential diagnosis
Acute schistosomiasis (Katayama fever) versus other acute febrile illness — Travel from endemic region 4-8 weeks earlier, eosinophilia, urticaria; serology
Cirrhosis of other etiology — Hepatitis B/C, alcohol; periportal fibrosis on imaging suggests Schistosoma
Bladder cancer (other causes) — S. haematobium predisposes to squamous cell carcinoma of the bladder; cystoscopy and biopsy
Urinary tract infection / hematuria from other causes — Stones, malignancy, glomerular disease
Pulmonary hypertension from other causes — Echo, right heart catheterization; schistosomiasis is a leading cause of PAH worldwide
Diagnostic workup
Diagnostic criteria
Identification of characteristic eggs in stool, urine, or biopsy is definitive. Serology supports diagnosis when eggs not recovered, especially in low-burden travelers and migrants.
Labs
Stool ovum and parasite (S. mansoni, japonicum)
Urine microscopy for eggs (S. haematobium) — best at midday, collected after exercise
Schistosoma serology by ELISA — sensitive for screening in low-burden travelers
Schistosoma PCR (where available)
CBC: eosinophilia (acute phase prominent, chronic less so)
LFTs, BMP
Rectal or bladder biopsy if eggs not recovered but suspicion high
CT/MRI to characterize hepatic, splenic, urinary findings
Cystoscopy for bladder polyps, ulcers, malignancy
Echo for pulmonary hypertension
MRI spine in suspected neuroschistosomiasis
Treatment
First-line
Praziquantel 40 mg/kg PO single dose (S. mansoni, S. haematobium) or 60 mg/kg PO divided over one day (S. japonicum, S. mekongi)
Repeat dose in 4-6 weeks may improve cure rates
For acute schistosomiasis (Katayama fever): supportive care with corticosteroids to dampen inflammatory response; delay praziquantel until 6-12 weeks post-exposure to allow eggs to mature (praziquantel kills only adult worms, not migrating schistosomula) — exact timing varies and some centers treat earlier with steroid coverage
Neuroschistosomiasis: praziquantel PLUS corticosteroids to reduce inflammation
Mass drug administration in endemic areas under WHO programs
Second-line / adjunct
Oxamniquine for S. mansoni in regions with availability (largely supplanted by praziquantel)
Surveillance for bladder cancer in chronic S. haematobium
Hepatic decompensation: management of portal hypertension including band ligation, beta-blockers; transplant in select cases
HIV co-management is important; female genital schistosomiasis facilitates HIV transmission
Complications
Hepatic fibrosis with portal hypertension, variceal bleeding
Squamous cell carcinoma of the bladder (chronic S. haematobium)
Hydronephrosis, chronic kidney disease
Pulmonary arterial hypertension (a globally important cause)
Cor pulmonale
Neuroschistosomiasis with permanent paraplegia or seizures
Female genital schistosomiasis with infertility, increased HIV risk
PANCE pearls
S. haematobium causes hematuria and predisposes to SQUAMOUS cell carcinoma of the bladder, in contrast to transitional cell carcinoma in other settings.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.